Subscribe to our press releases
ChromoGenics delivers I-Window glass to Kungsleden for an order value of approximately SEK 275 thousand
ChromoGenics AB (publ) has signed an agreement with Kungsleden to deliver I-Window glass to Kvartersakuten Mörby in Stockholm for a retro-fit project where existing glass is replaced with maintenance-free I-Window glass.
The project is a retro-fit project of about 60 sqm I-Window glass including construction work with planned delivery in the fourth quarter of 2018.
Kungsleden chose to upgrade the property’s windows to maintenance-free I-Window glass instead of traditional outside solar control systems. In the premises, a healthcare center conducts its activities.
“We are proud that Kungsleden chose to invest in I-Window glass to Kvartersakuten Mörby in Stockholm. ChromoGenics I-Window glass controls heating and cooling transmission in buildings, providing better indoor comfort with maintained views and healthy daylight. The order demonstrates the need for energy efficient and maintenance-free solar control solutions. Satisfied tenants and lower maintenance costs are important for all property owners and we are pleased that our I-Window glass can contribute to it,” says Jerker Lundgren, CEO of ChromoGenics.
Jerker Lundgren, CEO
Susanne Andersson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.